rss
Br J Ophthalmol 89:999-1003 doi:10.1136/bjo.2004.062596
  • Clinical science
    • Extended reports

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema

Table 3

 Change in intraocular pressure (IOP) during follow up

IOP (mm Hg) 2 mg group 5 mg group 13 mg group
Baseline 14.1 (1.4) 14.4 (1.4) 14.9 (1.2)
Maximal value 15.4 (1.7) 17.7 (2.7) 16.2 (2.0)
Maximal increase 1.5 (2.4) 3.6 (2.6) 1.3 (2.4)
At study end 14.9 (1.7) 16.7 (1.3) 15.6 (2.6)

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.